The price of Anrotinib is 1022 yuan per box, but the specific need to look at the local medical insurance policy.
Anrotinib is a new small molecule targeted therapeutic drug, mainly used in the treatment of advanced non-small cell lung cancer on the treatment of advanced non-small cell lung cancer, was included in the scope of health insurance in 2018, can enjoy the relevant reimbursement policy, most of the domestic areas of the price of a box of Anrotinib stays at about 1022 yuan, but the health insurance policy of each place is different, and there will be a small fluctuation.
Anrotinib can cause hand and foot skin reactions, hypertension, proteinuria and other adverse reactions, need to be used reasonably under the guidance of a doctor, during the use of medication also need to regularly check the liver function, renal function, and personal blood pressure and blood lipids, such as abnormalities need to be treated in a timely manner.